Michael Greenwood

Feature Writer

B.Sc. Chemistry, M.Sc. Drug Design and Discovery

Michael graduated from the University of Salford with a PhD in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.

Articles from Michael

What are Senolytics?

Senolytics, a class of drugs designed to specifically target senescent cells—those that have ceased cell division—are gaining recognition for their potential to address various age-related health issues.

27 Oct 2023

How Post Traumatic Growth Can Improve Your Health

Traumatic events, such as bereavement, serious illness, natural disasters, and war, can have enduring physical and psychological effects on individuals.

5 Oct 2023

Pharmaceutical Manufacturing Evolution: Mastering Process Development and Scale-Up for Market Success

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product quality.

5 Oct 2023

Ensuring Drug Safety and Quality: The Importance of Good Manufacturing Practice

Good Manufacturing Practice (GMP) is a system or protocol for ensuring product safety and consistency according to quality standards. Read more here.

4 Oct 2023

What is a Dose-Response Curve?

A dose-response curve is the graphical representation of a dose-response relationship, the magnitude of response of an organism from exposure to drugs and chemical interactors.

8 Sep 2023

What is Post-Operative Cognitive Decline?

Post-operative cognitive decline, or dysfunction (POCD), is a recognized clinical phenomenon in which patients experience lasting cognitive impairment following anesthesia.

7 Aug 2023

Applying Nanomedicine to Empower Humanity

Nanomedicines are small enough to enter cells and interact with cellular machinery in a manner not possible for small molecule therapeutics.

17 Jul 2023

Insight into the World of Psychedelic Therapies

Psychedelic-assisted therapies have attracted renewed attention in recent years as potentially more beneficial treatment options.

21 Jun 2023

Recent Technological Advancements in Medicines Manufacturing

The manufacture of medicines must draw on expertise from a wide range of disciplines, from the initial investigation and design of a new drug or therapeutic to wide-scale production and distribution.

3 May 2023

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

Doggybone DNA ™ (dbDNA) is a technology developed by biotech company Touchlight, which is a form of linear plasmid with applications in genetic engineering and therapeutics.

12 Apr 2023